PE 22-28 research peptide
A 7-residue peptide, Gly-Val-Ser-Trp-Gly-Leu-Arg, designed from degradation products of spadin and studied as a TREK-1 potassium channel blocker.
Sizes, prices and availability
| Size | SKU | Stated purity | Batch COA | Price | Availability | |
|---|---|---|---|---|---|---|
| 5 mg | PP-PE2228-5MG | Not yet provided | Not yet provided | $23.99 | In stock |
Prices and stock are checked at build time and refreshed live in your browser. Orders are US only for a flat $24.95 shipping fee. Shipping details
About PE 22-28
PE 22-28 is a seven-residue peptide that Djillani et al. (2017) designed from the blood degradation products of spadin, a secreted peptide derived from the propeptide of sortilin (neurotensin receptor 3) that blocks the two-pore-domain potassium channel TREK-1 (Mazella et al., 2010). Spadin corresponds to residues 12 to 28 of the propeptide, hence the name PE 12-28; PE 22-28 is its C-terminal seven residues.
Djillani et al. (2017) report that in patch-clamp experiments on human TREK-1-expressing HEK cells PE 22-28 inhibited the channel with an IC50 of 0.12 nM, against 40 to 60 nM for spadin, that modifications of its N- or C-terminal ends could keep or abolish channel activity, and that in mouse behavioural models and neuron cultures it and its derivatives produced antidepressant-like behaviour, neurogenesis and increased PSD-95 expression. They report an action duration of up to 23 hours against 7 hours for spadin. Mazella et al. (2010) report that spadin bound TREK-1 with an affinity of 10 nM and produced antidepressant-like effects in mice. This is cell and rodent work.
What the published literature covers
- Mazella et al. (2010) describe spadin as a sortilin-derived peptide that blocks TREK-1 and has antidepressant-like effects in mice.
- Moha Ou Maati et al. (2012) examine spadin for absence of TREK-1-related side effects.
- Djillani et al. (2017) describe the design of PE 22-28 and its analogues and their TREK-1 inhibition, stability and activity in mice.
- Djillani et al. (2019) review TREK-1 blockers, with a focus on spadin.
Vial arithmetic
The peptide reconstitution calculator converts a vial size, diluent volume and target amount into concentration, syringe units and draws per vial. Volumes convert to syringe units with the syringe units converter. It does arithmetic only and does not suggest any amount.
FAQ
Is Cerebrolysin a single peptide?
No. It is described as a mixture of low-molecular-weight peptides and amino acids derived from porcine brain proteins; LC-MS studies have identified hundreds to thousands of peptides in it.
What is PE 22-28?
A seven-residue peptide, GVSWGLR, designed from spadin degradation products. PubChem lists it as C35H55N11O9, 773.9 g/mol.
How does it relate to spadin?
Spadin is PE 12-28, a 17-residue peptide derived from the sortilin propeptide. PE 22-28 is its C-terminal seven residues, and Djillani et al. (2017) report it is longer acting in mice.
What does it act on in the literature?
The TREK-1 potassium channel. Djillani et al. (2017) report an IC50 of 0.12 nM in TREK-1-expressing HEK cells.
What sizes of PE 22-28 does Covalume list?
Covalume lists PE 22-28 in one size: 5 mg. Each size shows its price and live stock status in the variants table on this page.
How is the purity of PE 22-28 documented?
Each listing shows the purity the supplier states, labelled (supplier), and the batch Certificate of Analysis field reads "Not yet provided" until a batch-specific document is on file. Our guide to reading a Certificate of Analysis explains what HPLC and mass-spectrometry results show.
References
- Mazella J, Pétrault O, Lucas G, et al. (2010). Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol 8:e1000355. PubMed 20405001 · DOI
- Moha Ou Maati H, Veyssiere J, Labbal F, et al. (2012). Spadin as a new antidepressant: absence of TREK-1-related side effects. Neuropharmacology 62:278-88. PubMed 21807005 · DOI
- Djillani A, Pietri M, Moreno S, et al. (2017). Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity. Front Pharmacol 8:643. PubMed 28955242 · DOI
- Djillani A, Pietri M, Mazella J, et al. (2019). Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin. Pharmacol Ther 194:185-198. PubMed 30291907 · DOI
Identity values are from PubChem (CID 165437303) and the cited papers; for linear peptides the mass was also checked against the sequence. Last updated 2026-11-19.
Related research peptides
- Selank Synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
- Semax Synthetic ACTH(4-7)-Pro-Gly-Pro heptapeptide
- DSIP Nonapeptide first isolated from rabbit cerebral venous blood
- VIP Twenty-eight-residue neuropeptide (VPAC1 and VPAC2 receptor ligand)
- All neuropeptides peptides
From the research library
- Check the mass spectrometry on a COA yourself
- Peptide degradation pathways
- Peptide reconstitution: concentration and volume math
- Peptide purity vs peptide content: a vial mass balance
- How to read a COA HPLC chromatogram
- HPLC vs LC-MS for peptides: identity and purity workflow
- How to read an LC-MS trace: a worked peptide example
- TFA to acetate: peptide counter-ion exchange
- Peptide net charge, pI and solubility by pH
- Peptide adsorption to vials and plastics
- How long do peptides last? Stability evidence explained
- Bacteriostatic water vs sterile water